Free Trial
LON:CIZ

Cizzle Biotechnology (CIZ) Share Price, News & Analysis

Cizzle Biotechnology logo
GBX 1.67 +0.12 (+7.74%)
As of 07/18/2025 11:58 AM Eastern

About Cizzle Biotechnology (LON:CIZ)

Key Stats

Today's Range
1.40
1.70
50-Day Range
1.41
2.40
52-Week Range
1.25
2.69
Volume
239,687 shs
Average Volume
1.17 million shs
Market Capitalization
£6.58 million
Assets Under Management
£48.98 million
Dividend Yield
67.66%
Net Expense Ratio
0.46%
Aggregate Rating
N/A

ETF Overview

Cizzle Biotechnology Expenses

TypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFs
Management Fee0.40%0.58%0.56%0.45%0.53%
Other Expenses0.25%0.27%0.56%0.25%0.56%
Total Expense0.66%0.65%0.76%0.54%0.73%
Fee Waiver-0.20%-0.23%-0.66%-0.20%-0.63%
Net Expense0.46%0.62%0.63%0.47%0.60%
Receive CIZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

CIZ ETF News Headlines

Cizzle Biotechnology (LON:CIZ) Trading Up 3.6% - Should You Buy?
Miss This Window And You Miss Everything
There’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.
See More Headlines

CIZ ETF - Frequently Asked Questions

Cizzle Biotechnology's stock was trading at GBX 1.59 at the beginning of 2025. Since then, CIZ shares have increased by 5.1% and is now trading at GBX 1.67.

Cizzle Biotechnology Holdings Plc (LON:CIZ) released its earnings results on Wednesday, April, 30th. The company reported ($0.60) earnings per share (EPS) for the quarter.

Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cizzle Biotechnology investors own include Progressive (PGR), Qorvo (QRVO), TAL Education Group (TAL), Teekay Tankers (TNK), Waters (WAT), Preferred Apartment Communities (APTS) and Baidu (BIDU).

Fund Details

Issuer
Victory Capital Management
Fund Name
VictoryShares Developed Enhanced Volatility Wtd ETF
Tax Classification
Regulated Investment Company
Stock Exchange
LON
Current Symbol
LON:CIZ
Inception Date
9/30/2014
Fund Manager
Mannik Dhillon, Stephen Hammers

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
Global Ex-U.S.
Number of Holdings
505

Fund Statistics

Assets Under Management
$48.98 million
Average Daily Volume
$9.24 thousand
Discount/Premium
0.17%

Administrator, Advisor and Custodian

Administrator
Victory Capital Management Inc.
Advisor
Victory Capital Management Inc.
Custodian
Citibank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Options

Optionable
N/A
Short Interest
15,600 shs

Miscellaneous

Beta
0.38
Creation Unit
50,000
Creation Fee
$4,500.00
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Top 4 CIZ Holdings

  • Federated Treasury Obligations Fund
    Holding Weight: 100.00%
  • China Common Rich Ren
    Holding Weight: 0.00%
  • Constellation Software In
    Holding Weight: 0.00%
  • EVRAZ PLC
    Holding Weight: 0.00%

CIZ Sector Exposure

CIZ Industry Exposure


This page (LON:CIZ) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners